LSIPR 50 2018: It’s not like selling cars
Balancing a company’s duty to shareholders with the public responsibility to provide lifesaving treatments is a constant challenge, as Issi Rozen, chief business officer at the Broad Institute of MIT and Harvard, tells LSIPR.
Latest news
Medtech company backs down from Pfizer TM oppositions
14-08-2018
Medical technology company Biocompatibles UK last week withdrew its oppositions to two trademarks applied for by Pfizer, four months after settlement negotiations.
50 Key Influencers In The Life Sciences
- LSIPR 50 2018: Roy Waldron 14-08-2018
- LSIPR 50 2018: Elaine Waller 13-08-2018
Regions
- Combination SPCs: shaken and stirred 14-08-2018
- LSIPR 50 2018: Lorie Ann Morgan 10-08-2018
Sectors
- Combination SPCs: shaken and stirred 14-08-2018
- Hatch-Waxman amendment: a Hobson’s choice 08-08-2018
